Paper - WANFANG MED ONLINE

You Position: Home > Paper

液体活检在胰腺癌中的研究进展

( views:212, downloads:387 )

Author:: No author available

Journal Title:: Chinese Journal of Pancreatology

Issue:: 1

DOI:: 10.3760/cma.j.issn.1674-1935.2020.01.016

Key Word:: 液体活检;胰腺癌;生物标志物

Abstract：液体活检作为一种新兴技术，主要对循环肿瘤细胞(CTC)、循环肿瘤DNA(ctDNA)及肿瘤来源的外泌体进行检测，具有操作简便、快速、非侵入性、重复性强等优势，在肿瘤的早期诊断、治疗、进展与转移等领域发挥重要作用。本文分析液体活检技术的优势和局限性以及临床应用潜力和发展状况，对该技术在胰腺癌诊断、预测和治疗方面研究进展进行综述。

Reference

[1]Court, Colin M.,Ankeny, Jacob S.,Sho, Shonan,etc.Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer[J].2018,25(4).
[2]Bissolati, Massimiliano,Sandri, Maria Teresa,Burtulo, Giovanni,etc.Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer[J].2015,36(2).
[3]G D, Sorenson,D M, Pribish,F H, Valone,etc.Soluble normal and mutated DNA sequences from single-copy genes in human blood.[J].1900,3.
[4]Moffitt, Richard A.,Marayati, Raoud,Flate, Elizabeth L.,etc.Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma[J].2015,47(10).
[5]Nanjing Hao,John X.J. Zhang.Microfluidic Screening of Circulating Tumor Biomarkers toward Liquid Biopsy[J].2018,47(1).
[6]Yu Xu,Tai Qin,Jing Li,etc.Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.[J].2017,18(4).
[7]Funaki NO.,Kasamatsu T.,Ohshio G.,etc.Identification of Carcinoembryonic Antigen Mrna in Circulating Peripheral Blood of Pancreatic Carcinoma and Gastric Carcinoma Patients[J].1996,59(25/26).
[8]Ben-Izhak, Ofer,Greenberg, Orli,Hershkovitz, Dov,etc.Mutant KRAS Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring[J].2018,23(5).
[9]Sefrioui, David,Blanchard, France,Toure, Emmanuel,etc.Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours[J].2017,117(7).
[10]Manabu, Mikamori,Daisaku, Yamada,Hidetoshi, Eguchi,etc.MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma.[J].2017,7(Spec ).
[11]Andreas W, Berger,Daniel, Schwerdel,Thomas J, Ettrich,etc.Targeted deep sequencing of circulating tumor DNA in metastatic pancreatic cancer.[J].2018,9(2).
[12]Sackmann Eric K.,Fulton Anna L.,Beebe David J..The present and future role of microfluidics in biomedical research[J].2014,507(7491).
[13]Zarin Nuzhat,Carlos Palma,Gregory E. Rice,etc.Exosomes in pancreatic juice as valuable source of biomarkers for early diagnosis of pancreatic cancer[J].2017,6(S8).
[14]Nakano, Yutaka,Nakamura, Yuki,Hibi, Taizo,etc.KRAS mutations in cell- free DNA from preoperative and postoperative sera as a pancreatic cancer marker: a retrospective study[J].2018,118(5).
[15]Cohen, Joshua D.,Javed, Ammar A.,Thoburn, Christopher,etc.Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers[J].2017,114(38).
[16]Weian Sheng,Olomnseun O. Ogunwobi,Tao Chen.Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip[J].2014,14(1).
[17]Zhang W.,Xia W.,Lv Z.,etc.Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?[J].2017,41(2).
[18]Cheng, He,Liu, Chen,Jiang, Jiahao,etc.Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients[J].2017,140(10).
[19]Ankeny, J. S.,Court, C. M.,Hou, S.,etc.Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer[J].2016,114(12).
[20]Annachiara Mitrugno,Joanna L. Sylman,Anh T. P. Ngo,etc.Aspirin therapy reduces the ability of platelets to promote colon and pancreatic cancer cell proliferation: Implications for the oncoprotein c-MYC[J].2017,312(2 Pt.1).
[21]Erina, Takai,Yasushi, Totoki,Hiromi, Nakamura,etc.Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer.[J].2015,5.
[22]Sujuan Yang,Sara P. Y. Che,Paul Kurywchak,etc.Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer[J].2017,18(3).
[23]Kahlert,C.,Melo,S.A.,Protopopov,A.,etc.Identification of doublestranded genomic dna spanning all chromosomes with mutated KRAS and P53 DNA in the serum exosomes of patients with pancreatic cancer[J].2014,289(7).
[24]Hitoshi Kondo,Kokichi Sugano,Noriko Fukayama,etc.Detection of point mutations in the K‐ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma[J].1994,73(6).
[25].A signal-amplifiable biochip quantifies extracellular vesicle-associated RNAs for early cancer detection.[J].2017,8(1).
[26]Wan, Jonathan C. M.,Massie, Charles,Garcia-Corbacho, Javier,etc.Liquid biopsies come of age: towards implementation of circulating tumour DNA[J].2017,17(4).
[27]Melo Sonia A.,Luecke Linda B.,Kahlert Christoph,etc.Glypican-1 identifies cancer exosomes and detects early pancreatic cancer[J].2015,523(7559).
[28]Ko, Jina,Bhagwat, Neha,Yee, Stephanie S.,etc.Combining Machine Learning and Nanofluidic Technology To Diagnose Pancreatic Cancer Using Exosomes[J].2017,11(11).
[29]Lu Han,Wei Chen,Qicheng Zhao.Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis.[J].2014,35(3).
[30]O, Nordg?rd,K, Tjensvoll,B, Gilje,etc.Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer.[J].2018,105(2).
[31]Chetan, Bettegowda,Mark, Sausen,Rebecca J, Leary,etc.Detection of circulating tumor DNA in early- and late-stage human malignancies.[J].2014,6(224).